No description
-
2010 (v1)PublicationUploaded on: April 14, 2023
-
2016 (v1)Publication
Background and aim Cerebral ischemia is characterized by both acute and delayed neuronal injuries. Neuro-protection is a major issue that should be properly addressed from a pharmacological point of view, and cell-based treatment approaches are of interest due to their potential pleiotropic effects. Endothelial progenitor cells have the...
Uploaded on: April 14, 2023 -
2012 (v1)Publication
Objective: To describe the application of intraoperative monitoring techniques during aneurysm surgery and to discuss the advantages and limitations of these techniques in prevention of postoperative neurologic deficits. Methods: Articles found in the literature through PubMed for the time frame 1980-2011 and the authors' personal files were...
Uploaded on: March 27, 2023 -
2009 (v1)Publication
Schilder's disease, or myelinoclastic diffuse sclerosis, is a rare disorder characterised by an inflammatory white matter plaque of demyelination. Clinical signs and symptoms might be atypical for early multiple sclerosis and at imaging the lesion is easily taken for a brain tumour. Regardless of the use of Poser's criteria for clinical...
Uploaded on: March 27, 2023 -
2013 (v1)PublicationGenetic and cellular basis of cerebral cavernous malformations: Implications for clinical management
Cerebral cavernous malformations (CCMs) are a diffuse cerebrovascular disease affecting approximately 0.5% of the population. A CCM is characterized by abnormally enlarged and leaky capillaries arranged in mulberry-like structures with no clear flow pattern. The lesion might predispose to seizures, focal neurological deficits or fatal...
Uploaded on: March 27, 2023